We have an abundance of articles which address the impact of psychotropic medications on pregnancy. Â Much less research, however, has focused on how pregnancy may affect how these medications work. Physiologic changes take place during [...]
A light week. Untreated perinatal paternal depression: Effects on offspring. Gentile S, Fusco ML.Psychiatry Res. 2017 Jun;252:325-332. Review. Â Untreated perinatal paternal depression negatively affects child development. Â Family-centred approaches may improve the effectiveness of perinatal mental [...]
We have long been interested in understanding the effects of prenatal exposure to antidepressants on the development of the fetal brain. Â The earliest studies addressing this question were small but yielded detailed (and reassuring) information [...]
There a few new articles on the impact of antidepressant use during pregnancy. Â Viktorin and colleagues demonstrated no increase in risk for intellectual disability in children with prenatal exposure to antidepressants. Â Rai and colleagues demonstrated [...]
While different countries may have different attitudes toward the consumption of alcohol during pregnancy, the American Academy of Pediatrics (AAP) has taken a firm stand against the use of alcohol during pregnancy. In the report [...]
The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: July 3, 2017  Over the last 2 decades, there has been a growing interest in establishing a rich [...]
Happy Fourth of July! Â This week there are several articles on the use of antipsychotics during pregnancy (Tosato et al and Park et al). The highlight of this week is an article from Man and [...]
It is estimated that suicide accounts for about 10% of all maternal deaths. While we have a fair amount of information to help us predict which women are at risk for depression during pregnancy and [...]
In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression. Â SAGE-547, now called brexanolone, is a new type of antidepressant: a formulation of allopregnanolone, which is [...]
While many women are at risk for postpartum depression, we continue to struggle in providing adequate support and care to women in this setting, especially socioeconomically disadvantaged women. Â In a randomized clinical trial including [...]
